✦ LIBER ✦

Activity of taxol (T) by 3 h infusion in breast cancer patients (pts) with clinical resistance to anthracyclines (A)

✍ Scribed by Munzone, E.; Capri, G.; Demicheli, R.; Villani, F.; Brambilla, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ifosfamide given by continuous-intraveno

✍ C. Campisi; A. Fabi; P. Papaldo; S. Tomao; B. Massidda; A. Zappala; M. T. Ionta; 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 69 KB

378 Taxol® (paclitaxel) 225 mg/m2 b

✍ Ph. Bougnoux; R. Delva; D. Serin; M. Namer; G. Piot; J.P. Lotz; J.F. Ramée; E. V 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 170 KB

An EORTC-IDBBC phase I study of gemcitab

✍ A Awada; L Biganzoli; T Cufer; L Beex; C Lohrisch; V Batter; A Hamilton; M Nooij 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 101 KB

5021 Everolimus (RAD001) in combination

✍ S. Hurvitz; R. O'Regan; M. Campone; C. Manlius; L. Vittori; P. Mukhopadhyay; C. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Clinical response and plasma levels of 5

✍ Hillcoat, B L; McCulloch, P B; Figueredo, A T; Ehsan, M H; Rosenfeld, J M 📂 Article 📅 1978 🏛 Nature Publishing Group 🌐 English ⚖ 651 KB

Induction, mobilization of peripheral bl

✍ Weaver, C H; West, W H; Schwartzberg, L S; Alberico, T; Leff, R; Greco, F A; Hai 📂 Article 📅 1997 🏛 Nature Publishing Group 🌐 English ⚖ 133 KB